HR 5364
116th Congress
House
Health
Asia
Australia
Canada
Department of Health and Human Services
Europe
Executive agency funding and structure
France
Germany
Health care costs and insurance
Health programs administration and funding
Indian social and development programs
Inflation and prices
Italy
Japan
Medicaid
Medical research
Medicare
Netherlands
North America
End Price Gouging for Insulin Act
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 14, 2020
Referred to the Subcommittee on Health.
Dec 18, 2019
Referred to the Subcommittee for Indigenous Peoples of the United States.
Dec 10, 2019
Referred to the Subcommittee on Health.
Dec 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2019
Introduced in House
Plain-English summary
End Price Gouging for Insulin Act
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
What's happening now
Referred to the Subcommittee on Health.